News

Filter

Current filters:

HumiraAbbVie

1 to 9 of 41 results

EMA explains its redaction rules, responding to Ombudsman questions

EMA explains its redaction rules, responding to Ombudsman questions

11-02-2015

The European Medicines Agency has published a detailed response to the European Ombudsman’s questions…

AbbVieEuropeHumiraPharmaceuticalRegulation

AbbVie fourth-qtr beats forecasts, but posts Shire-associated $810 million loss

AbbVie fourth-qtr beats forecasts, but posts Shire-associated $810 million loss

31-01-2015

US drugmaker AbbVie on Friday announced financial results for the fourth quarter and full year 2014,…

AbbVieAnti-Arthritics/RheumaticsAnti-viralsFinancialHumiraPharmaceuticalViekira Pak

AbbVie issues earnings-per-share guidance up 30% for 2015

AbbVie issues earnings-per-share guidance up 30% for 2015

12-01-2015

US drugmaker AbbVie has issued updated guidance about its expected earnings in 2015.

AbbVieAnti-viralsFinancialHumiraPharmaceuticalUSAViekira Pak

NICE says ‘yes’ to Remicade, Humira and Simponi for ulcerative colitis

NICE says ‘yes’ to Remicade, Humira and Simponi for ulcerative colitis

12-12-2014

UK health care cost watchdog the National Institute for Health and Care Excellence (NICE) has issued…

AbbVieGastro-intestinalsHumiraMerck & CoPharmaceuticalPricingRegulationRemicadeSimponi InjectionUK

Zydus launches world’s first biosimilar of Humira

Zydus launches world’s first biosimilar of Humira

09-12-2014

A biosimilar of AbbVie’s blockbuster drug Humira (adalimumab) has been launched in India by generic…

AbbVieAnti-Arthritics/RheumaticsBiosimilarsHumiraIndiaMarkets & MarketingZydus Cadila

Stada Arz and mAbxience to negotiate over adalimumab biosimilar

21-11-2014

German drugmaker Stada Arzneimittel and the biotech specialist mAbxience have agreed to negotiate over…

AbbVieadalimumabAnti-Arthritics/RheumaticsBiosimilarsBiotechnologyHumiraLicensingMabxienceSTADA Arzneimittel

EMA responds to Ombudsman questioning of AbbVie trial redactions

13-11-2014

The European Medicines Agency says it has taken note of the European Ombudsman’s recent remarks on…

AbbVieAnti-Arthritics/RheumaticsEuropeHumiraPharmaceuticalRegulationResearch

AbbVie, still fuelled by Humira, beats own and analysts’ forecasts

AbbVie, still fuelled by Humira, beats own and analysts’ forecasts

01-11-2014

Just a couple of weeks after abandoning its $54 billion “tax inversion” motivated takeover of Ireland-headquartered…

AbbVieAnti-Arthritics/RheumaticsFinancialHumiraPharmaceuticalShireUSA

1 to 9 of 41 results

Back to top